Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04997499 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adolescent Subcutaneous (SQ) Injection Video Validation

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Enrolling by Invitation to Active, Not Recruitingv6
  2. Notable Primary completion date: Sep 2023 to Dec 2026 Completion date: Dec 2023 to Dec 2026v5 Show 1 more changeShow less
    • Completion date: Dec 2023 to Dec 2026
  3. Notable Primary completion date: Aug 2022 to Sep 2023 Completion date: Dec 2022 to Dec 2023v4 Show 1 more changeShow less
    • Completion date: Dec 2022 to Dec 2023
  4. Minor Start date changed from estimate of Sep 30, 2021 to Sep 29, 2021v3
  5. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation Start date: Aug 2021 to Sep 30, 2021 · Study sites: 0 to 1v2 Show 2 more changesShow less
    • Start date: Aug 2021 to Sep 30, 2021
    • Study sites: 0 to 1
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter muscular injection. Self administration can be done at home and therefore offers an alternative to traveling to a medical office.
Trial Details
NCT Number NCT04997499
Lead Sponsor Tufts Medical Center
Conditions Medication Compliance, Contraception, Self-Evaluation
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov